University of Washington Reading & Dyslexia Research Program
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03945097 |
|
Recruitment Status : Unknown
Verified May 2019 by Jason Yeatman, University of Washington.
Recruitment status was: Recruiting
First Posted : May 10, 2019
Last Update Posted : May 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Reading Disability | Behavioral: preK |
| Study Type : | Observational |
| Estimated Enrollment : | 44 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | University of Washington Reading & Dyslexia Research Program |
| Estimated Study Start Date : | May 2019 |
| Estimated Primary Completion Date : | June 2021 |
| Estimated Study Completion Date : | June 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Letters
Education program focuses on learning letters.
|
Behavioral: preK
Subjects enter and education program that either focuses on learning letters and their corresponding sounds or on language comprehension skills. |
|
Language
Education program focuses on language comprehension.
|
- Letter Knowledge [ Time Frame: Within 2 weeks post intervention ]Knowledge of letter names and sounds. This is computed as percent correct (out of 52). Each child is shown a flash card with each upper case letter and asked to name it and say its sound
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 60 Months to 72 Months (Child) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria: Typically developing children enrolled before kindergarten.
- Typically developing child between 60 and 72 months of age
- Has not yet begun Kindergarten
Exclusion Criteria:
- Reported neurological or psychiatric condition.
- Claustrophobia. ADHD
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03945097
| Contact: Patrick Donnelly | 206-685-9365 | pdonne@uw.edu |
| United States, Washington | |
| University of Washignton | Recruiting |
| Seattle, Washington, United States, 98195 | |
| Contact: Jason Yeatman, PhD | |
| Principal Investigator: | Jason Yeatman, PhD | University of Washington |
| Responsible Party: | Jason Yeatman, Assistant Professor, Institute for Learning & Brain Sciences, Dept. of Speech & Hearing Services, University of Washington |
| ClinicalTrials.gov Identifier: | NCT03945097 |
| Other Study ID Numbers: |
STUDY00000516 1R21HD092771-01A1 ( U.S. NIH Grant/Contract ) |
| First Posted: | May 10, 2019 Key Record Dates |
| Last Update Posted: | May 10, 2019 |
| Last Verified: | May 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Dyslexia Language Disorders Communication Disorders Neurobehavioral Manifestations Neurologic Manifestations |
Nervous System Diseases Learning Disabilities Neurodevelopmental Disorders Mental Disorders |

